Search

everythinglearnresearchcommunity

for

Search:↓

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Finasteride effectively treats baldness but may cause sexual side effects.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

A male with aromatase deficiency improved bone health with estradiol treatment.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Finasteride effectively treats male hair loss, improving growth and density.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride doesn't affect bone density in male rats.

Male hormones worsen kidney transplant damage, but blocking them helps.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Both genetic and lifestyle factors significantly affect female hair loss.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Phthirusa pyrifolia extract may lower testosterone and harm male rat reproduction without damaging the liver or kidneys.